Please login to the form below

Not currently logged in
Email:
Password:

Langland opens New York office

Marks the UK health advertising agency's first over-seas venture
Langland Philip Chin

Langland has opened its first office outside of the UK in a move that follows its acquisition last year by Publicis Healthcare Communications Group (PHCP).

The agency's New York office is situated within its parent group's corporate headquarters in the city and will be led by Langland's managing partner Kate Spencer.

She said: “Specifically in the field of clinical trial patient recruitment, Langland has amassed extensive experience and expertise having supported global pharma companies with over 350 studies across 75 countries.

“The US continues to be a key region in the world from where pharma companies both co-ordinate and conduct global clinical trails. Having an on-the-ground presence directly in the US will provide us with a greater opportunity to work more closely with our US-based clients.”

Publicis Health acquired the independent Windsor-based health advertising agency in December last year, noting at the time that rather than rebrand Langland it wants to focus instead on the global replication of its multi-award-winning brand.

Philip Chin, Langland's chief executive, said: “Our strategy is to scale and replicate the Langland brand internationally as part of Publicis Health to better serve the needs of our clients.

“Our new office in New York is a significant step forward in executing this strategy.”

The healthcare advertising agency was named Cannes Lions Health Agency of the Year in 2014 and 2015 and added to its awards cabinet at the PM Society's Digital Awards 2016 earlier this week.

The firm took home the gold in animation for its JINARC MoA for Otsuka and in social media and film for the spoof 'STI Detection Unit' campaign, Sniffers, for Radox Laboratories.

Article by
Rebecca Clifford

3rd May 2016

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics